Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. Kcl1998001079
2. Krp 297
3. Krp-297
4. Krp297
5. L 410198
6. L-410198
7. L410198
8. Mk 767
9. Mk-767
10. Mk767 Cpd
1. Krp-297
2. 213252-19-8
3. Krp297
4. Mk 767
5. Mk-767
6. Krp 297
7. 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-n-[[4-(trifluoromethyl)phenyl]methyl]benzamide
8. 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-n-[4-(trifluoromethyl)benzyl]benzamide
9. 5-((2,4-dioxothiazolidin-5-yl)methyl)-2-methoxy-n-(4-(trifluoromethyl)benzyl)benzamide
10. 5-(2,4-dioxo-thiazolidin-5-ylmethyl)-2-methoxy-n-(4-trifluoromethyl-benzyl)-benzamide
11. Mk767 Cpd
12. 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-n-{[4-(trifluoromethyl)phenyl]methyl}benzamide
13. L410198
14. L 410198
15. Kcl1998001079
16. Schembl3922
17. Mls006010319
18. L-410198
19. Gtpl2677
20. Dtxsid90870239
21. Akos005067111
22. Ncgc00263123-01
23. Ac-31436
24. Benzamide, 5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-n-((4-(trifluoromethyl)phenyl)methyl)-
25. Smr004701384
26. Hy-119248
27. Cs-0077355
28. E98692
29. Q27086690
30. N-(4-trifluoromethylbenzyl)-5-(2,4-dioxothiazolidin-5-yl)methyl-2-methoxybenzamide
31. 5-[(2,4-dioxothiazolidin-5-yl) Methyl]-2-methoxy-n-[[4-(trifluoromethyl)phenyl]methyl] Benzamide
| Molecular Weight | 438.4 g/mol |
|---|---|
| Molecular Formula | C20H17F3N2O4S |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 438.08611269 g/mol |
| Monoisotopic Mass | 438.08611269 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 653 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
79
PharmaCompass offers a list of Benzamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benzamide manufacturer or Benzamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benzamide manufacturer or Benzamide supplier.
PharmaCompass also assists you with knowing the Benzamide API Price utilized in the formulation of products. Benzamide API Price is not always fixed or binding as the Benzamide Price is obtained through a variety of data sources. The Benzamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Benzamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benzamide, including repackagers and relabelers. The FDA regulates Benzamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benzamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Benzamide supplier is an individual or a company that provides Benzamide active pharmaceutical ingredient (API) or Benzamide finished formulations upon request. The Benzamide suppliers may include Benzamide API manufacturers, exporters, distributors and traders.
click here to find a list of Benzamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benzamide DMF (Drug Master File) is a document detailing the whole manufacturing process of Benzamide active pharmaceutical ingredient (API) in detail. Different forms of Benzamide DMFs exist exist since differing nations have different regulations, such as Benzamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benzamide DMF submitted to regulatory agencies in the US is known as a USDMF. Benzamide USDMF includes data on Benzamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benzamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benzamide suppliers with USDMF on PharmaCompass.
Benzamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benzamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benzamide GMP manufacturer or Benzamide GMP API supplier for your needs.
A Benzamide CoA (Certificate of Analysis) is a formal document that attests to Benzamide's compliance with Benzamide specifications and serves as a tool for batch-level quality control.
Benzamide CoA mostly includes findings from lab analyses of a specific batch. For each Benzamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benzamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Benzamide EP), Benzamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benzamide USP).
